![Animals | Free Full-Text | Clinical Use of a 180-Day Implantable Glucose Monitoring System in Dogs with Diabetes Mellitus: A Case Series Animals | Free Full-Text | Clinical Use of a 180-Day Implantable Glucose Monitoring System in Dogs with Diabetes Mellitus: A Case Series](https://www.mdpi.com/animals/animals-12-00860/article_deploy/html/images/animals-12-00860-g001.png)
Animals | Free Full-Text | Clinical Use of a 180-Day Implantable Glucose Monitoring System in Dogs with Diabetes Mellitus: A Case Series
Longevity, accuracy, flexibility, discretion. Four important qualities of diabetes care that only the Eversense E3 CGM System delivers to… | Instagram
![FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements - NotebookCheck.net News](https://www.notebookcheck.net/fileadmin/Notebooks/News/_nc3/Eversense_CGM_system_90_day_now_180_days_blood_glucose_drdNBC.jpg)